Silence Therapeutics plc·4

Jul 10, 8:36 AM ET

Griffiths Richard Ian 4

4 · Silence Therapeutics plc · Filed Jul 10, 2025

Insider Transaction Report

Form 4
Period: 2025-07-07
Transactions
  • Purchase

    American Depositary Shares

    2025-07-08+24,38711,657,232 total
    Exercise: $5.94Ordinary Shares (73,161 underlying)
  • Purchase

    American Depositary Shares

    2025-07-07+7,93711,632,845 total
    Exercise: $5.65Ordinary Shares (23,811 underlying)
  • Purchase

    American Depositary Shares

    2025-07-09+30,13311,687,365 total
    Exercise: $6.00Ordinary Shares (90,399 underlying)
Footnotes (1)
  • [F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.

Documents

1 file
  • 4
    tm2520411-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT